Xiangming Mao

743 total citations · 1 hit paper
20 papers, 503 citations indexed

About

Xiangming Mao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Xiangming Mao has authored 20 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Xiangming Mao's work include RNA modifications and cancer (4 papers), Prostate Cancer Treatment and Research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Xiangming Mao is often cited by papers focused on RNA modifications and cancer (4 papers), Prostate Cancer Treatment and Research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Xiangming Mao collaborates with scholars based in China, United States and France. Xiangming Mao's co-authors include Zining Long, Weibo Zhong, Xumin Zhou, Jianming Lü, Chuanfan Zhong, Daojun Lv, Kaihui Wu, Taowei Yang, Yufei Guo and Junqi Luo and has published in prestigious journals such as Bioinformatics, Journal of Hazardous Materials and Frontiers in Immunology.

In The Last Decade

Xiangming Mao

18 papers receiving 502 citations

Hit Papers

Gut dysbiosis promotes prostate cancer progression and do... 2022 2026 2023 2024 2022 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis
    2022 132 citations Weibo Zhong, Kaihui Wu et al. Microbiome profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangming Mao China 11 310 207 138 96 47 20 503
Chuanfan Zhong China 8 267 0.9× 175 0.8× 94 0.7× 69 0.7× 24 0.5× 20 381
Caiyong Lai China 13 259 0.8× 118 0.6× 68 0.5× 59 0.6× 25 0.5× 37 427
Wang Li China 11 218 0.7× 119 0.6× 60 0.4× 50 0.5× 29 0.6× 37 348
Dan Kong China 14 306 1.0× 181 0.9× 42 0.3× 78 0.8× 42 0.9× 34 538
Xufeng Huang Hungary 12 160 0.5× 94 0.5× 71 0.5× 109 1.1× 55 1.2× 26 364
Shahriar Hashemzadeh Iran 14 255 0.8× 162 0.8× 38 0.3× 45 0.5× 30 0.6× 41 471
Fei Xiong China 14 306 1.0× 117 0.6× 43 0.3× 94 1.0× 75 1.6× 39 526
Tangzhiming Li China 10 344 1.1× 154 0.7× 126 0.9× 44 0.5× 109 2.3× 24 537
Vilma Maldonado Mexico 9 189 0.6× 162 0.8× 70 0.5× 95 1.0× 69 1.5× 11 394
Judith Bellemare Canada 13 289 0.9× 79 0.4× 95 0.7× 120 1.3× 11 0.2× 18 594

Countries citing papers authored by Xiangming Mao

Since Specialization
Citations

This map shows the geographic impact of Xiangming Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangming Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangming Mao more than expected).

Fields of papers citing papers by Xiangming Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangming Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangming Mao. The network helps show where Xiangming Mao may publish in the future.

Co-authorship network of co-authors of Xiangming Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangming Mao. A scholar is included among the top collaborators of Xiangming Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangming Mao. Xiangming Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shen, Qiang, Wu Jun, Jiaxing Wang, et al.. (2025). CircATP2C1 Drives Prostate Cancer Progression Through miR-654-3p-Mediated SLC7A11 Upregulation and Ferroptosis Suppression. Cancers. 17(21). 3571–3571. 1 indexed citations
3.
4.
Wu, Jun, Daojun Lv, Wanmei Lin, et al.. (2024). Chronic exposure to liquid crystal monomer EBCN at environmentally relevant concentrations induces testicular dysfunction via the gut-testis axis. Journal of Hazardous Materials. 486. 137033–137033. 5 indexed citations
5.
Chen, Wen‐Bin, Yutao Zhan, Wenfeng Li, et al.. (2024). Exosome-delivered NR2F1-AS1 and NR2F1 drive phenotypic transition from dormancy to proliferation in treatment-resistant prostate cancer via stabilizing hormonal receptors. Journal of Nanobiotechnology. 22(1). 761–761. 1 indexed citations
6.
Fu, Hao, et al.. (2024). Case report: A case of primary renal osteosarcoma. Medicine. 103(30). e39024–e39024.
7.
Zhong, Chuanfan, Zining Long, Taowei Yang, et al.. (2023). M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy. International Journal of Biological Sciences. 19(5). 1543–1563. 39 indexed citations
8.
Luo, Junqi, Taowei Yang, Jun Wu, et al.. (2023). Exosomal PGAM1 promotes prostate cancer angiogenesis and metastasis by interacting with ACTG1. Cell Death and Disease. 14(8). 40 indexed citations
9.
Wu, Jun, Fuming Deng, Xiangliang Tang, et al.. (2023). Long-term effect of PBDE-99 prenatal exposure on spermatogenic injuries via the dysregulation of autophagy. Journal of Hazardous Materials. 452. 131234–131234. 9 indexed citations
10.
Long, Zining, Jianming Lü, Shuo Wang, et al.. (2023). A five-pseudouridylation-associated-LncRNA classifier for primary prostate cancer prognosis prediction. Frontiers in Genetics. 13. 1110799–1110799. 2 indexed citations
11.
Zou, Libin, Wenbin Chen, Xumin Zhou, et al.. (2022). N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability. Cell Death Discovery. 8(1). 184–184. 33 indexed citations
12.
Zhong, Weibo, Kaihui Wu, Zining Long, et al.. (2022). Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis. Microbiome. 10(1). 94–94. 132 indexed citations breakdown →
13.
Zhong, Weibo, et al.. (2022). Knowledge mapping and current trends of immunotherapy for prostate cancer: A bibliometric study. Frontiers in Immunology. 13. 1014981–1014981. 15 indexed citations
14.
Wu, Jun, Fuming Deng, Xiangliang Tang, et al.. (2022). Long-Term Effect of Pbde-99 Prenatal Exposure on Spermatogenic Injuries Via the Dysregulation of Autophagy. SSRN Electronic Journal. 1 indexed citations
15.
Lü, Jianming, Chuanfan Zhong, Junqi Luo, et al.. (2021). HnRNP-L-regulated circCSPP1/miR-520h/EGR1 axis modulates autophagy and promotes progression in prostate cancer. Molecular Therapy — Nucleic Acids. 26. 927–944. 33 indexed citations
16.
Zhou, Xumin, Libin Zou, Hangyu Liao, et al.. (2021). Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer. Acta Pharmaceutica Sinica B. 12(2). 692–707. 78 indexed citations
17.
Wang, Ke, Weibo Zhong, Zining Long, et al.. (2021). 5-Methylcytosine RNA Methyltransferases-Related Long Non-coding RNA to Develop and Validate Biochemical Recurrence Signature in Prostate Cancer. Frontiers in Molecular Biosciences. 8. 775304–775304. 22 indexed citations
18.
Wang, Jiahong, Lingfeng Zhao, Hua‐Feng Wang, et al.. (2019). GenCLiP 3: mining human genes’ functions and regulatory networks from PubMed based on co-occurrences and natural language processing. Bioinformatics. 36(6). 1973–1975. 67 indexed citations
19.
20.
Shi, Rong, et al.. (2009). [Literature-mining and bioinformatic analysis of androgen-independent prostate cancer-specific genes].. PubMed. 15(12). 1102–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuanfan Zhong Breakdown of academic impact, for papers by Caiyong Lai Breakdown of academic impact, for papers by Wang Li Breakdown of academic impact, for papers by Dan Kong Breakdown of academic impact, for papers by Xufeng Huang Breakdown of academic impact, for papers by Shahriar Hashemzadeh Breakdown of academic impact, for papers by Fei Xiong Breakdown of academic impact, for papers by Tangzhiming Li Breakdown of academic impact, for papers by Vilma Maldonado Breakdown of academic impact, for papers by Judith Bellemare
Rankless by CCL
2026